Skip to content
Julia Wigren Byström is the CEO of Xerum, who is now nominated to the prestigious award MedTech4Health Innovation Award. The award recognizes good role models when it comes to implementing medical technology in everyday life. Foto: Emil Byström
Julia Wigren Byström is the CEO of Xerum, who is now nominated to the prestigious award MedTech4Health Innovation Award. The award recognizes good role models when it comes to implementing medical technology in everyday life. Foto: Emil Byström

Press release -

Xerum nominated for the prestigous MedTech4Health Innovation Award

During the Covid pandemic, Xerum became nationally known for its self sampling and one of the world's most sensitive antibody test. Now the Umeå company has been nominated for the MedTech4Health Innovation Award.

Xerum AB is a spin-off company from the Department of Clinical Microbiology at Umeå University. The company, which receives business support from the Umeå Biotech Incubator, was founded in 2020 by associate professor Mattias Forsell, associate professor Johan Normark specialist in infectious diseases, and biomedical analyst Julia Wigren Byström. Xerum has developed a sensitive methodology for the analysis of SARS-CoV-2 antibodies in capillary blood and serum. During the pandemic, the antibody test has been used for self-sampling in Region Västerbotten, and the company has performed antibody tests several times in national surveys, on behalf of the Public Health Authority (Folkhälsomyndigheten). Today, the product is used, among other things, by FHM to plan vaccine dosing in risk groups.

Now Xerum is being noticed again as the company is one of three nominees for the MedTech4Health Innovation Award. The award recognizes good role models when it comes to implementing medical technology in everyday life.

- It feels great to be nominated for the award. It's extra honorable that it's a prize for patient benefit, because it's something we're really passionate about, says Xerum's CEO, Julia Wigren Byström.

The winners will be awarded on May 23 at the Nordics' leading e-health meeting Vitalis at the Swedish Fair, Gothenburg. The jury will also, for the first time, this year appoint a Patient's Prize to the project from all the nominations that is judged to be of greatest benefit to patients, users and citizens.

Other nominees for the MedTech4Health Innovation Award:

Tobias Granberg, section manager Neuroradiology Medical Unit, Karolinska University Hospital, who together with partners developed an AI tool for earlier and more accurate diagnosis of MS patients during MRI examinations.

Stig Steen, former professor and senior physician, and Johan Nilsson, senior physician and lecturer at Skåne University Hospital and Lund University, have developed a transport box for hearts before transplants.

Topics

Categories


Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Contacts

Tomas Ruuth

Tomas Ruuth

Press contact Head of PR & Communications PR & Communications 072-4024697 www.ubi.se

Related content

Xerum has performed and analyzed around 10 000 tests during the pandemic. Now Julia Wigren Byström (to the right), CEO of Xerum, and Linnea Vikström will get new tests to analyze. Foto: Emil Byström

New national assignment for Xerum

The Umeå company Xerum has received a new national assignment to measure the presence of antibodies against SARS-CoV-2, the virus that causes covid-19 in Sweden. Xerum has performed and analyzed around 10 000 tests during the pandemic.

Julia Wigren Byström, CEO of Xerum.

Xerum assigned by Swedish Public Health Agency to measure number of Swedes with antibodies against SARS-CoV-2

Umeå-based Xerum launched a home testing kit in March that detects antibodies against SARS-CoV-2 - the virus that causes Covid-19. Uptake of the kits was strong, and now the company has been given an important assignment by the Swedish Public Health Agency. “We will be responsible for the distribution and analysis of our self-sampling kits as part of a large study” says Julia Wigren Byström, CEO.

We grow ideas that can change the world

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Umeå Biotech Incubator
Umeå Biotech Incubator

Tvistevägen 48C
907 36 Umeå
Sweden